These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 848925)

  • 1. Effects of purines and pyrimidines on the fungistatic activity of 5-fluorocytosine in Aspergillus species.
    Wagner GE; Shadomy S
    Antimicrob Agents Chemother; 1977 Feb; 11(2):229-33. PubMed ID: 848925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. II. Studies on distribution and incorporation.
    Polak A; Scholer HJ
    Pathol Microbiol (Basel); 1973; 39(5):334-7. PubMed ID: 4580714
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the mode of action of 5-fluorocytosine in Aspergillus species.
    Wagner GE; Shadomy S
    Chemotherapy; 1979; 25(2):61-9. PubMed ID: 156110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole].
    Goudard M; Regli P; Buffard Y; Gabriel B
    Pathol Biol (Paris); 1988 Feb; 36(2):139-43. PubMed ID: 3279381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. I. Reversal experiments.
    Polak A; Scholer HJ
    Pathol Microbiol (Basel); 1973; 39(2):148-59. PubMed ID: 4575668
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination.
    Lauer BA; Reller LB; Schröter GP
    J Antimicrob Chemother; 1978 Jul; 4(4):375-80. PubMed ID: 690038
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology.
    J Antimicrob Chemother; 1984 Jul; 14(1):1-8. PubMed ID: 6480540
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
    Shadomy S; Wagner G; Espinel-Ingroff E; Davis BA
    Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity to 5-fluorocytosine and virulence for mice of some human isolates of Aspergillus.
    Nobre G
    Mycopathologia; 1977 Nov; 62(1):57-60. PubMed ID: 413042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of 5-fluorocytosine on nucleic acid synthesis in Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.
    Polak A; Wain WH
    Chemotherapy; 1977; 23(4):243-59. PubMed ID: 324722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.
    Kitahara M; Seth VK; Medoff G; Kobayashi GS
    Antimicrob Agents Chemother; 1976 Jun; 9(6):915-9. PubMed ID: 820247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro sensitivity to 5-fluorocytosine of strains isolated from patients under treatment for chromomycosis.
    Gonzaga de Oliveira L; Aparecida de Rezende M; Osorio Cisalpino E; Peixoto de Figueiredo Y; Ferreira Lopes C
    Int J Dermatol; 1975 Mar; 14(2):141-3. PubMed ID: 1123261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism of polyene antibiotics with 5-fluorocytosine.
    Polak A
    Chemotherapy; 1978; 24(1):2-16. PubMed ID: 338264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticandidal activity of 5-fluorocytosine-peptide conjugates.
    Steinfeld AS; Naider F; Becker JM
    J Med Chem; 1979 Sep; 22(9):1104-9. PubMed ID: 385880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of 5-fluorocytosine and 5-fluorouracil in dematiaceous fungi.
    Polak A
    Sabouraudia; 1983 Mar; 21(1):15-25. PubMed ID: 6221418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
    Beggs WH; Andrews FA; Sarosi GA
    Chemotherapy; 1981; 27(4):247-51. PubMed ID: 7195793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
    Segal E; Romano A; Eylan E; Stein R
    Chemotherapy; 1975; 21(6):358-66. PubMed ID: 1183243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole.
    Yamaguchi H; Uchida K; Nagino K; Matsunaga T
    J Infect Chemother; 2002 Dec; 8(4):374-7. PubMed ID: 12525904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.